Resorbable Scaffold Beats Angioplasty in Below-Knee CLTI : v

A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.

Related Keywords

United States , Sydney , New South Wales , Australia , Duke University Medical Center , North Carolina , San Francisco , California , Boston , Massachusetts , Georgia , American , Jennifer Rymer , David Kandzari , Ramon Varcoe , Provisio Medical Inc , Abiomed , Peidmont Heart Institute In Atlanta , Medtronic , Pfizer , Boston Scientific Corporation , Vesteck Inc , Philips , Abbott Vascular , Transcatheter Cardiovascular Therapeutics , Wales Hospital , Superior Efficacy , African American , Peidmont Heart Institute , Thenew England Journal , Bard Medical , Cook Medical , Provisio Medical , Cardiovascular Therapeutics , Peripheral Vascular Disease , Percutaneous Coronary Intervention , Arteries , Drug Eluting Stent , Limbs , Stent , Amputation , Perioperative , Implanted Device Cardiology , Endovascular Stent , Endovascular Techniques ,